Generics Co. Rips Novartis' Bid To Combine Reclast Suits
Wockhardt USA LLC told a New Jersey federal judge Tuesday that three patent infringement suits launched by Novartis Pharmaceuticals Corp. seeking to block drugmakers from developing generic versions of its osteoporosis...To view the full article, register now.
Already a subscriber? Click here to view full article